Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Colt Ventures

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
The average size of a deal this fund participated in
Portfolio companies 9
Rounds per year 0.33
Lead investments 2
Exits 3
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Biopharma
  • Therapeutics
  • Pharmaceutical

Colt Ventures appeared to be the VC, which was created in 1995. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Dallas.

The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 5 - 10 millions dollars. The increased amount of exits for fund were in 2018. The important activity for fund was in 2017.

We also calculated 1 valuable employee in our database.

The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are City Hill Ventures, Silicon Valley Bank, RBV Capital. In the next rounds fund is usually obtained by Silicon Valley Bank, City Hill Ventures.

The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Ignyta, Bonti.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Colt Ventures:
Typical Co-investors
Colt Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Colt Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Changjiangyun China, Hubei, Wuhan
Compass Global Fund -
GE Healthcare Connecticut, Fairfield, United States
Hecai Jijin -
humbition New York, New York, United States
InitioGroup British Columbia, Canada, Vancouver
INTAGE Open Innovation Fund -
Invertidos Andalucia, Málaga, Spain
IRDI-ICSO France, Midi-Pyrenees, Toulouse
Nilo Ventures California, San Francisco, United States
Novartis Institutes Cambridge, Massachusetts, United States
Pit Crew -
Qurate Retail Colorado, Englewood, United States
Santen Ventures -
Shanghai Only Education Group China, Shanghai
UpHonest Capital California, San Francisco, United States
VAM Investments Canton Esch-sur-Alzette, Esch-sur-Alzette, Luxembourg

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Alterome Therapeutics

$35M02 Nov 2022 San Diego, California, United States

Odyssey Therapeutics

Health Care
$218M07 Dec 2021 Cambridge, Massachusetts, United States


Consumer Goods
Subscription Service
$6M30 Aug 2021 New York, New York, United States

Content Creators
Content Delivery Network
Content Discovery
Content Syndication
Video Streaming
20 May 2021 Old Toronto, Ontario, Canada


Emergency Medicine
Health Care
Life Science
$200M27 Apr 2020 San Diego, California, United States

ReCode Therapeutics

Health Care
$80M26 Mar 2020 Dallas, Texas, United States

Silverback Therapeutics

Health Care
$78M11 Mar 2020 Seattle, Washington, United States


Clinical Trials
Medical Device
$11M19 Apr 2017 California, United States


Health Care
Health Diagnostics
$5M31 Dec 2012 San Diego, California, United States
ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million

– ReCode Therapeutics announced the closing of an $80m Series B financing round co-led by Pfizer Ventures and EcoR1 Capital.
– The round was led by Pfizer Ventures and EcoR1 Capital.
– New investors include Sanofi Ventures, funds managed by Tekla Capital Management, Superstring Capital and NS Investment.
– Existing investors who participated included OrbiMed, Vida Ventures, MPM Capital, Colt Ventures, Hunt Technology Ventures, and Osage University Partners.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Colt Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: